1Crowd leads early VC round in India's Rymo Technologies
What's the deal? 1CrowdDealroom has a profile for this one. Try Dealroom → has led an early-stage venture round in Rymo TechnologiesDealroom has a profile for this one. Try Dealroom →, an Indian health-tech company that builds robotic and AI-driven physical rehabilitation systems. The investment, announced in November 2026, expands 1Crowd's healthcare portfolio.
What does Rymo do? It makes robotic rehabilitation systems, balance trainers, and virtual reality-based tools, with functional electrical stimulation devices in the works. Its pitch rests on price: imported systems can cost US$135.8K-US$203.7K, while Rymo says its solutions are about 10 times cheaper.
Why it matters: By cutting costs, Rymo aims to put robotic rehabilitation within reach of smaller physiotherapy centres and patients' homes, not just large hospitals — targeting neurological and orthopaedic recovery.
What's the endgame? "We want to make high-quality rehabilitation more effective and accessible," said co-founder and chief executive officer Chirag Shah. Co-founder and partner Natasha Kothari said 1Crowd backs businesses that "bridge access and delivery gaps through technology."
Why now? The deal follows a US$1.36M seed round led by IAN Angel Fund in March, earmarked for product development, manufacturing, and expansion — so the new backing marks a further investor endorsement rather than Rymo's first major financing.
The signal: India's rehabilitation tech space is heating up, with neurorehab startup xStepDealroom has a profile for this one. Try Dealroom → drawing funding from Titan CapitalDealroom has a profile for this one. Try Dealroom → in September. The bet here is on widening access beyond major hospitals; the test will be whether Rymo can sustain adoption and show clinical outcomes as it scales.
Read more: lokmattimes.com
Image credit: Generated with Gemini
